Net profit of Nath Bio-Genes (India) declined 0.24% to Rs 33.35 crore in the quarter ended June 2024 as against Rs 33.43 crore during the previous quarter ended June 2023. Sales rose 3.66% to Rs 243.88 crore in the quarter ended June 2024 as against Rs 235.28 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales243.88235.28 4 OPM %14.9815.74 - PBDT34.4334.38 0 PBT33.6033.62 0 NP33.3533.43 0 Powered by Capital Market - Live News

Nath Bio-Genes (India) will hold a meeting of the Board of Directors of the Company on 7 August 2024.Powered by Capital Market - Live News

Nath Bio-Genes (India) announced that the Annual General Meeting (AGM) of the company will be held on 17 August 2024.Powered by Capital Market - Live News

Net profit of Nath Bio-Genes (India) rose 80.69% to Rs 2.62 crore in the quarter ended March 2024 as against Rs 1.45 crore during the previous quarter ended March 2023. Sales declined 4.33% to Rs 43.04 crore in the quarter ended March 2024 as against Rs 44.99 crore during the previous quarter ended March 2023.For the full year,net profit rose 13.10% to Rs 39.62 crore in the year ended March 2024 as against Rs 35.03 crore during the previous year ended March 2023. Sales rose 10.37% to Rs 332.62 crore in the year ended March 2024 as against Rs 301.36 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales43.0444.99 -4 332.62301.36 10 OPM %9.138.74 -14.9916.18 - PBDT3.272.66 23 41.3839.18 6 PBT2.281.67 37 38.1136.16 5 NP2.621.45 81 39.6235.03 13 Powered by Capital Market - Live News

Nath Bio-Genes (India) announced that the Board of Directors of the Company at its meeting held on 08 May 2024, has recommended a Final dividend of Rs.2 per share (i.e.20%), subject to the approval of the shareholders.Powered by Capital Market - Live News